Francisco Martinez Murillo - Comment

Document ID: FDA-2011-D-0577-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: August 30 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 27 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 15 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 14 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f09766
View Document:  View as format xml

View Comment

In pg 12/22, omit "who" in: Patient Tolerance for Risk: Patients "who" are willing to take the risk of having the device implanted even for a small probability of benefit because they have no other treatment options and their symptoms are severe In pgs 14 and 15/22, add "Approval/Non-Approval Considerations:" header, to the last paragraphs of Examples 2 and 3. In the spirit of transparency and to allow a better understanding of FDA's decision making process, it may be useful to add the file number reference for the different examples of Section 5.2, Examples Based on Actual FDA Benefit-Risk Determinations.

Related Comments

    View All
Total: 15
Francisco Martinez Murillo - Comment
Public Submission    Posted: 09/27/2011     ID: FDA-2011-D-0577-0003

Nov 14,2011 11:59 PM ET
NeuroPace, Inc. - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2011-D-0577-0004

Nov 14,2011 11:59 PM ET
Novartis - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0005

Nov 14,2011 11:59 PM ET
Stephanie Bechtold - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0006

Nov 14,2011 11:59 PM ET
Roche Diagnostics - Comment
Public Submission    Posted: 12/16/2011     ID: FDA-2011-D-0577-0007

Nov 14,2011 11:59 PM ET